Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 3546 entries
View as:

Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis

Phase: N/A Priority: Normal
NCT ID: NCT01733862 Org: User:
Start: 11/27/12 End: 02/08/17 Due: 02/08/18

A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom

Phase: N/A Priority: Normal
NCT ID: NCT01292213 Org: User:
Start: 05/31/12 End: 02/28/13 Due: 02/28/14

A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00608699 Org: User:
Start: 12/31/07 End: 04/30/08 Due: 04/30/09

COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00273052 Org: User:
Start: 01/05/06 End: 12/28/07 Due: 12/28/08

Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults

Phase: N/A Priority: Normal
NCT ID: NCT03162614 Org: User:
Start: 05/24/17 End: 09/24/18 Due: 09/24/19

Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).

Phase: N/A Priority: Normal
NCT ID: NCT00404261 Org: User:
Start: 01/31/07 End: 08/31/07 Due: 08/31/08

A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01915914 Org: User:
Start: 12/23/13 End: 02/15/15 Due: 02/15/16

Study to Assess the Effect Of Alosetron On Mucosal Blood Flow

Phase: N/A Priority: Normal
NCT ID: NCT00370032 Org: User:
Start: 12/31/06 End: 12/31/07 Due: 12/31/08

Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)

Phase: N/A Priority: Normal
NCT ID: NCT00426751 Org: User:
Start: 10/31/06 End: 12/31/07 Due: 12/31/08

Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion

Phase: N/A Priority: Normal
NCT ID: NCT01128972 Org: User:
Start: 08/31/09 End: 10/31/09 Due: 10/31/10

An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)

Phase: N/A Priority: Normal
NCT ID: NCT00875784 Org: User:
Start: 05/06/08 End: 06/14/08 Due: 06/14/09

A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01943864 Org: User:
Start: 09/19/13 End: 02/01/16 Due: 02/01/17

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

Phase: N/A Priority: Normal
NCT ID: NCT00387387 Org: User:
Start: 10/20/06 End: 08/14/09 Due: 08/14/10

A Drug Interaction Study With Albiglutide and Warfarin

Phase: N/A Priority: Normal
NCT ID: NCT01147731 Org: User:
Start: 06/04/10 End: 09/09/10 Due: 09/09/11

A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh

Phase: N/A Priority: Normal
NCT ID: NCT00139334 Org: User:
Start: 06/30/05 End: 01/31/06 Due: 01/31/07

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Phase: N/A Priority: Normal
NCT ID: NCT00726323 Org: User:
Start: 06/30/06 End: 08/18/10 Due: 08/18/11

A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

Phase: N/A Priority: Normal
NCT ID: NCT01245426 Org: User:
Start: 12/31/10 End: 08/31/11 Due: 08/31/12

Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00320385 Org: User:
Start: 11/30/05 End: 10/31/10 Due: 10/31/11

Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials

Phase: N/A Priority: Normal
NCT ID: NCT05100316 Org: User:
Start: 12/16/21 End: 10/04/22 Due: 10/04/23

Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting

Phase: N/A Priority: Normal
NCT ID: NCT01013948 Org: User:
Start: 02/28/09 End: 05/31/09 Due: 05/31/10

Long-term Safety Study for GSK573719 in Japanese

Phase: N/A Priority: Normal
NCT ID: NCT01702363 Org: User:
Start: 08/31/12 End: 12/31/13 Due: 12/31/14

A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00606697 Org: User:
Start: 12/19/07 End: 05/07/08 Due: 05/07/09

Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05064358 Org: User:
Start: 03/03/22 End: 01/30/26 Due: 01/30/27

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT06613698 Org: User:
Start: 09/27/24 End: 08/23/27 Due: 08/23/28

Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00158795 Org: User:
Start: 01/31/05 End: 07/31/05 Due: 07/31/06